My concern with the two bills we are considering today is that as drafted they would undermine public health, discourage pharmaceutical research, and undermine the FDA's central capacity to ensure medical products used on patients have demonstrated safety and efficiency.
Gene Green expresses concern that the bills could harm public health and FDA's role.
Share
More from Gene Green
The Centers for Disease Control and Prevention reports that more than 700 women in the United States die each year due to complications related to pregnancy and childbirth.
I'm happy to once again support my colleague Mr. Engel's bill, to rein in this dangerous practice.
The Cures Act aimed to build on the progress of the HITECH Act of 2009, but by focusing on improving interoperability, patient access to their health records, and reducing provider burden.
Other voices in this conversation
